Tobias Maetzig

3.1k total citations
47 papers, 2.1k citations indexed

About

Tobias Maetzig is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Tobias Maetzig has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 27 papers in Genetics and 8 papers in Hematology. Recurrent topics in Tobias Maetzig's work include Virus-based gene therapy research (26 papers), CRISPR and Genetic Engineering (26 papers) and RNA Interference and Gene Delivery (22 papers). Tobias Maetzig is often cited by papers focused on Virus-based gene therapy research (26 papers), CRISPR and Genetic Engineering (26 papers) and RNA Interference and Gene Delivery (22 papers). Tobias Maetzig collaborates with scholars based in Germany, United States and Canada. Tobias Maetzig's co-authors include Axel Schambach, Melanie Galla, Christopher Baum, Daniela Zychlinski, Ute Modlich, Martijn H. Brugman, Christopher Baum, Johannes Kuehle, Tobias Cantz and Rainer Loew and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Tobias Maetzig

46 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tobias Maetzig Germany 22 1.7k 1.2k 489 175 133 47 2.1k
Ali Nowrouzi Germany 19 1.5k 0.9× 999 0.8× 550 1.1× 183 1.0× 69 0.5× 28 2.0k
Daniela Cesana Italy 16 1.6k 1.0× 1.4k 1.2× 580 1.2× 223 1.3× 76 0.6× 24 2.2k
Samuel L. Murphy United States 13 1.5k 0.9× 1.2k 1.1× 528 1.1× 177 1.0× 152 1.1× 27 2.0k
Fabrizio Benedicenti Italy 14 1.4k 0.9× 1.3k 1.1× 540 1.1× 176 1.0× 90 0.7× 27 1.9k
Steven J. Howe United Kingdom 27 1.9k 1.1× 1.6k 1.4× 532 1.1× 234 1.3× 61 0.5× 48 2.5k
Cynthia C. Bartholomae Germany 20 2.5k 1.5× 2.0k 1.7× 673 1.4× 221 1.3× 80 0.6× 33 3.0k
Jennifer E. Adair United States 26 1.3k 0.8× 683 0.6× 568 1.2× 314 1.8× 220 1.7× 64 1.9k
Fabian Gross France 8 1.5k 0.9× 1.4k 1.2× 585 1.2× 247 1.4× 83 0.6× 15 2.2k
Melanie Galla Germany 26 1.7k 1.0× 1.1k 0.9× 670 1.4× 506 2.9× 67 0.5× 48 2.5k
Klaus Kühlcke Germany 16 1.1k 0.7× 1.1k 0.9× 622 1.3× 421 2.4× 178 1.3× 27 1.8k

Countries citing papers authored by Tobias Maetzig

Since Specialization
Citations

This map shows the geographic impact of Tobias Maetzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Maetzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Maetzig more than expected).

Fields of papers citing papers by Tobias Maetzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Maetzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Maetzig. The network helps show where Tobias Maetzig may publish in the future.

Co-authorship network of co-authors of Tobias Maetzig

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Maetzig. A scholar is included among the top collaborators of Tobias Maetzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Maetzig. Tobias Maetzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Selich, Anton, et al.. (2022). A pro B cell population forms the apex of the leukemic hierarchy in Hoxa9/Meis1-dependent AML. Leukemia. 37(1). 79–90. 1 indexed citations
2.
Schambach, Axel, et al.. (2021). An Improved Lentiviral Fluorescent Genetic Barcoding Approach Distinguishes Hematopoietic Stem Cell Properties in Multiplexed In Vivo Experiments. Human Gene Therapy. 32(19-20). 1280–1294. 5 indexed citations
3.
Bošnjak, Berislav, Marc Permanyer, Maya K. Sethi, et al.. (2018). CRISPR/Cas9 Genome Editing Using Gold‐Nanoparticle‐Mediated Laserporation. Advanced Biosystems. 2(11). 19 indexed citations
4.
Maetzig, Tobias, Michael Morgan, & Axel Schambach. (2018). Fluorescent genetic barcoding for cellular multiplex analyses. Experimental Hematology. 67. 10–17. 6 indexed citations
5.
Maetzig, Tobias, et al.. (2017). Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic Cells. Molecular Therapy — Methods & Clinical Development. 6. 54–65. 13 indexed citations
6.
Norddahl, Gudmundur L., Tobias Maetzig, Patricia M. Rosten, et al.. (2017). Meis2 as a critical player in MN1-induced leukemia. Blood Cancer Journal. 7(9). e613–e613. 15 indexed citations
7.
Kuehle, Johannes, Soeren Turan, Tobias Cantz, et al.. (2014). Modified Lentiviral LTRs Allow Flp Recombinase–mediated Cassette Exchange and In Vivo Tracing of “Factor-free” Induced Pluripotent Stem Cells. Molecular Therapy. 22(5). 919–928. 20 indexed citations
8.
Maetzig, Tobias, Johannes Kuehle, Adrian Schwarzer, et al.. (2014). All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinase. Biomaterials. 35(14). 4345–4356. 20 indexed citations
9.
Schott, Juliane W., Dirk Hoffmann, Tobias Maetzig, et al.. (2014). Improved retroviral episome transfer of transcription factors enables sustained cell fate modification. Gene Therapy. 21(11). 938–949. 10 indexed citations
10.
Zwingenberger, Stefan, Zhenyu Yao, Angela Jacobi, et al.. (2013). Enhancement of BMP-2 Induced Bone Regeneration by SDF-1α Mediated Stem Cell Recruitment. Tissue Engineering Part A. 20(3-4). 3922858313–3922858313. 42 indexed citations
11.
Maetzig, Tobias, Christopher Baum, & Axel Schambach. (2012). Retroviral Protein Transfer: Falling Apart to Make an Impact. Current Gene Therapy. 12(5). 389–409. 7 indexed citations
12.
Galla, Melanie, Axel Schambach, Christine S. Falk, et al.. (2012). Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Research. 40(2). 939–939. 47 indexed citations
13.
Maetzig, Tobias, Martijn H. Brugman, Stefan Bartels, et al.. (2011). Polyclonal fluctuation of lentiviral vector–transduced and expanded murine hematopoietic stem cells. Blood. 117(11). 3053–3064. 46 indexed citations
14.
Lachmann, Nico, Dirk Heckl, Sebastian Brennig, et al.. (2011). MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy. Gene Therapy. 19(9). 915–924. 13 indexed citations
15.
Heinz, Niels, Axel Schambach, Melanie Galla, et al.. (2010). Retroviral and Transposon-Based Tet-Regulated All-In-One Vectors with Reduced Background Expression and Improved Dynamic Range. Human Gene Therapy. 22(2). 166–176. 74 indexed citations
16.
Suerth, Julia D., Tobias Maetzig, Melanie Galla, Christopher Baum, & Axel Schambach. (2010). Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design. Journal of Virology. 84(13). 6626–6635. 54 indexed citations
17.
Galla, Melanie, Tobias Maetzig, Johannes Kuehle, et al.. (2010). Protein transduction from retroviral Gag precursors. Proceedings of the National Academy of Sciences. 107(17). 7805–7810. 117 indexed citations
18.
Modlich, Ute, Susana Navarro, Daniela Zychlinski, et al.. (2009). Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors. Molecular Therapy. 17(11). 1919–1928. 289 indexed citations
19.
Zychlinski, Daniela, Axel Schambach, Ute Modlich, et al.. (2008). Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors. Molecular Therapy. 16(4). 718–725. 215 indexed citations
20.
Schambach, Axel, Melanie Galla, Tobias Maetzig, Rainer Loew, & Christopher Baum. (2007). Improving Transcriptional Termination of Self-inactivating Gamma-retroviral and Lentiviral Vectors. Molecular Therapy. 15(6). 1167–1173. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Nowrouzi Breakdown of academic impact, for papers by Daniela Cesana Breakdown of academic impact, for papers by Samuel L. Murphy Breakdown of academic impact, for papers by Fabrizio Benedicenti Breakdown of academic impact, for papers by Steven J. Howe Breakdown of academic impact, for papers by Cynthia C. Bartholomae Breakdown of academic impact, for papers by Jennifer E. Adair Breakdown of academic impact, for papers by Fabian Gross Breakdown of academic impact, for papers by Melanie Galla Breakdown of academic impact, for papers by Klaus Kühlcke
Rankless by CCL
2026